Advisory Committee on Immunization Practices will be meet again on Friday, it is expected the pause on the J&J product will be lifted with an advisory being issued not to use heparin should there be any issue with clotting. I had been mistaken with respect to the number of adverse reactions involved with the J&J pause. It involved 6 individuals, all female, between the ages of 18 and 48.